home / lobbying

lobbying_activities

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

980 rows where filing_year = 2008 and issue_code = "PHA" sorted by filing_year descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: filing_type, is_termination, received_date (date)

filing_period 4

  • first_quarter 251
  • second_quarter 250
  • third_quarter 247
  • fourth_quarter 232

issue_code 1

  • PHA · 980 ✖

filing_year 1

  • 2008 · 980 ✖
id filing_uuid filing_type registrant_name registrant_id client_name filing_year ▲ filing_period issue_code specific_issues government_entities income_amount expense_amount is_no_activity is_termination received_date
584041 GILBERT'S LLP 746335fc-d173-4892-87ef-6c4d28069226 Q1 GILBERT'S LLP 67876 MYLAN LABORATORIES INC 2008 first_quarter PHA Enforcement and possible reform of the legislation and regulations relating to drug approval Federal Trade Commission (FTC),HOUSE OF REPRESENTATIVES,SENATE 90000   0 0 2008-03-16T14:52:31-04:00
584053 FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) 42229c61-3956-46d2-ad4d-98a7f7ede2d5 Q1 FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) 86196 PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) 2008 first_quarter PHA Monitor legislative developments in health care HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2008-03-16T14:52:31-04:00
584133 CUBIST PHARMACEUTICALS, INC. 3dfd6614-1f8a-41dd-8dd4-4a5e8ea10275 Q1 CUBIST PHARMACEUTICALS, INC. 40026226 CUBIST PHARMACEUTICALS 2008 first_quarter PHA Medical Research Prescription drug/Federal Drug Admin/Center for Disease Control/Health and Human Service issues Antibiotic Resistance issues H.R. 1174, Healthy Hospitals Act H.R. 3697, Strategies to Address Antimicrobial Resistance Act H.R. 4352, Antimicrobial Task Force in public schools H.R. 4451, MRSA Research and Study Act S. 2278, Community and Healthcare Associated Infections Reduction Act S. 2313, Strategies to Address Antimicrobial Resistance Act S. 2525, MRSA Infection Prevention and Patient Protection Act S. 2526, Worker Infection Protection Act Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA)   131329 0 0 2008-03-16T14:52:31-04:00
584208 FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) 88060b61-fcdb-4ca4-aea7-7a2e47d7d4ee Q3 FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) 86196 PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) 2008 third_quarter PHA Monitor legislative developments in health care HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2008-03-23T11:31:28-04:00
584243 FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) f18cb41d-e309-4dd7-8753-77af83ceb53f Q2 FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) 86196 PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) 2008 second_quarter PHA Monitor legislative developments in health care HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2008-03-23T11:31:28-04:00
584306 FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) 2abcaf92-e25a-4119-9f86-4f49903f4bd4 Q4 FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) 86196 PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) 2008 fourth_quarter PHA Monitor legislative developments in health care HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2008-03-23T11:31:28-04:00
584462 AMERICAN CAPITOL GROUP dbad19b4-2f6c-41e7-b874-3d61db0a70b9 Q1 AMERICAN CAPITOL GROUP 305852 DISPENSING SOLUTIONS INC 2008 first_quarter PHA Drug Importation, Phrmacy, Counterfiet Drugs   10000   0 0 2008-03-27T15:26:05-04:00
584495 MAYBERRY & ASSOCIATES, LLC 33a4d27d-fd41-49dc-9bd3-8b1f5b6802d8 Q1 MAYBERRY & ASSOCIATES, LLC 51968 HEALTHCARE COMPLIANCE PACKAGING COUNCIL 2008 first_quarter PHA Pharmaceutical regimen compliance. Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE     0 0 2008-03-31T08:37:18-04:00
584501 MAYBERRY & ASSOCIATES, LLC 45a8246b-d13e-4a9a-a033-40da7c118f7c Q1 MAYBERRY & ASSOCIATES, LLC 51968 PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION 2008 first_quarter PHA Food, Drug and Cosmetic Act. Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE     0 0 2008-03-31T09:07:23-04:00
584531 RUBICON ADVISORS, LLC 7f1c5857-b976-4b2b-b419-16e623cd0fd8 3A RUBICON ADVISORS, LLC 315091 TEVA PHARMACEUTICALS USA 2008 third_quarter PHA Patent Settlements H.R. 1432 S. 316, Generic Biologics S. 1695 H.R. 5629, Physician Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100   105000   0 0 2008-03-31T09:38:35-04:00
584533 RUBICON ADVISORS, LLC 8eb52607-8398-47aa-ac2b-6728cf93f6f3 Q4 RUBICON ADVISORS, LLC 315091 TEVA PHARMACEUTICALS USA 2008 fourth_quarter PHA Patent Settlements H.R. 1432 S. 316, Generic Biologics S. 1695 H.R. 5629, Physician Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100   105000   0 0 2008-03-31T09:38:35-04:00
584738 GO DADDY.COM 57979701-a29e-48a1-9e02-7755fa32357f Q1 GO DADDY.COM 303553 GO DADDY COM 2008 first_quarter PHA S.980 Controlled Substances Act Federal Communications Commission (FCC),Federal Trade Commission (FTC),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Telecommunications & Information Administration (NTIA),SENATE,State, Dept of (DOS)   143500 0 0 2008-04-01T15:03:58-04:00
584821 INDEPENDENT PHARMACY COOPERATIVE 60bcf8a5-b712-46df-a230-b0189cdde21a Q1 INDEPENDENT PHARMACY COOPERATIVE 313098 INDEPENDENT PHARMACY COOPERATIVE 2008 first_quarter PHA S. 195 and H.R. 3140 Fair Medicaid Reimbursement (AMP), S.1954 and H.R. 1474 (Medicare Part D Prompt Payment) Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE   10000 0 0 2008-04-02T10:41:06-04:00
585212 KIRKLAND & ELLIS LLP 789a17ac-303e-41dc-b8c4-3031278c6cc7 Q1 KIRKLAND & ELLIS LLP 21745 TEVA PHARMACEUTICALS USA 2008 first_quarter PHA House and Senate legislation on biologic medicines. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2008-04-04T10:57:42-04:00
585488 MARSHALL BRACHMAN 372e1532-7a69-447c-9025-de0c0d8d9b9e Q1 MARSHALL BRACHMAN 6848 STEWART JACKSON PHARMACAL 2008 first_quarter PHA Senate HELP Committee and House Energy and Commerce Committee: monitor FDA legislation related to regulation of pharmaceutical manufacturing HOUSE OF REPRESENTATIVES,SENATE 6000   0 0 2008-04-06T19:18:00-04:00
585517 DUTKO WORLDWIDE, LLC f10a48b2-9536-4c5a-b328-ccbeb0161759 Q1 DUTKO WORLDWIDE, LLC 12868 IBIS BIOSCIENCES 2008 first_quarter PHA Counsel and advise regarding attempts to secure federal procurement contracts for a biosensor device. Agriculture, Dept of (USDA),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA)     0 0 2008-04-07T09:48:46-04:00
585680 INTERNATIONAL COMMERCE DEVELOPMENT CORP 5ce78fac-c78c-4abe-a19d-e3c5bfefacbd Q1 INTERNATIONAL COMMERCE DEVELOPMENT CORP 286278 AMPHASTAR PHARMACEUTICALS INC 2008 first_quarter PHA Seeking general pharmaceuticals approvals for client from the FDA and EPA. Environmental Protection Agency (EPA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 170000   0 0 2008-04-07T13:18:22-04:00
585771 VAN FLEET ASSOCIATES b055fbb0-4886-40e5-80bb-f6e21a020dfc 1T VAN FLEET ASSOCIATES 39781 AMERICAN COUNCIL ON REGULATORY COMPLIANCE 2008 first_quarter PHA Over the counter salesof productsthat contain ephedrine and psedoephedrine. Drug Enforcement Administration (DEA),Food & Drug Administration (FDA)     0 1 2008-04-07T15:00:08-04:00
585812 VAN FLEET ASSOCIATES 9aed0cfd-114e-41d3-bbd8-440b23c6a67b Q1 VAN FLEET ASSOCIATES 39781 KIRK PHARMACEUTICALS 2008 first_quarter PHA FDA and DEA regulation pertaining to over the counter drug sales. Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2008-04-07T16:07:49-04:00
585934 DUTKO WORLDWIDE, LLC b85442be-d5c5-4aef-87e4-d8ebb6efc046 Q1 DUTKO WORLDWIDE, LLC 12868 MEDIMPACT HEALTHCARE SYSTEMS 2008 first_quarter PHA Work with CMS on the role of PBM's in delivering the Medicare Part D benefit and related operational issues. Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2008-04-08T10:13:11-04:00
585949 DUTKO WORLDWIDE, LLC 6489bb7a-1985-4610-a045-bcaa0ddb07ba Q1 DUTKO WORLDWIDE, LLC 12868 NEWAYS INTERNATIONAL 2008 first_quarter PHA Monitor legislation pertaining to dietary supplements and pharmaceuticals, particularly S. 762. Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2008-04-08T10:29:25-04:00
586288 CYBER SECURITY RESEARCH CONSULTANTS, LLC 73800857-a950-433e-a92a-be30543b4efb Q1 CYBER SECURITY RESEARCH CONSULTANTS, LLC 91694 PDFRAZER CONSULTING INC CANADIAN INTERNATIONAL PHARMACY ASSOCIATION 2008 first_quarter PHA Monitoring Dorgan/Snowe drug re-importation from Canada HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2008-04-08T18:58:36-04:00
586333 BROYDRICK & ASSOCIATES 49ad7797-e62f-407c-8960-15686d0915bc Q1 BROYDRICK & ASSOCIATES 7268 BARR LABORATORIES 2008 first_quarter PHA Patent reform, Generic Biologies       0 0 2008-04-09T09:33:27-04:00
587014 GREENLEE PARTNERS, LLC 7ca20ec0-4221-4f07-90ea-19cc33a6b865 Q1 GREENLEE PARTNERS, LLC 79995 PFIZER 2008 first_quarter PHA pharmaceutical bills HOUSE OF REPRESENTATIVES,SENATE     0 0 2008-04-10T11:12:07-04:00
587032 DUTKO WORLDWIDE, LLC 7e6c201a-9826-474b-9a18-78e130f1a07a 1A DUTKO WORLDWIDE, LLC 12868 MEDIMPACT HEALTHCARE SYSTEMS 2008 first_quarter PHA Work with CMS on the role of PBM's in delivering the Medicare Part D benefit and related operational issues. Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2008-04-10T11:25:25-04:00
587130 DUTKO WORLDWIDE, LLC 27379b88-bbcc-4334-90c9-58d122c20da7 1A DUTKO WORLDWIDE, LLC 12868 NEWAYS INTERNATIONAL 2008 first_quarter PHA Monitor legislation pertaining to dietary supplements and pharmaceuticals, particularly S. 762. Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2008-04-10T12:51:30-04:00
587244 VENABLE LLP c8a9cf08-1092-4787-8482-f876a313a230 Q1 VENABLE LLP 39941 ENDO PHARMACEUTICALS INC 2008 first_quarter PHA General issues affecting the pharmaceutical industry. HOUSE OF REPRESENTATIVES,SENATE     0 0 2008-04-10T14:40:40-04:00
587561 MEREDITH MCGEHEE 08937eb9-102e-4f46-bc5a-47fc66d30735 Q1 MEREDITH MCGEHEE 79858 INTERNATIONAL AIDS VACCINE INITIATIVE 2008 first_quarter PHA funding for programs to develop AIDS vaccine targeted toward the developing world; research and development programs aimed at the AIDS epidemic; tax issues affecting AIDS vaccine programs; patent issues related to vaccine development; reauthorization of PEPFAR; appropriation for IAVI   21600   0 0 2008-04-11T10:33:46-04:00
587701 THE OB-C GROUP, LLC 7b0090cd-3ed0-41d8-92b5-cf666af54929 Q1 THE OB-C GROUP, LLC 29802 ELI LILLY 2008 first_quarter PHA S 3, Medicare Prescription Drug Price Negotiation Act of 2007: Medicare program. HR 4, Medicare Prescription Drug Price Negotiation Act of 2007: Medicare program. HR 5629, Pathway for Biosimilars Act: biologics. S 1695, Biologics Price Competition and Innovation Act of 2007: biologics. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2008-04-11T12:00:05-04:00
588099 AMERICAN SOCIETY OF CONSULTANT PHARMACISTS d4ff6d00-cd77-4a94-9ea8-dc9e55a1d120 Q1 AMERICAN SOCIETY OF CONSULTANT PHARMACISTS 3446 AMERICAN SOCIETY OF CONSULTANT PHARMACISTS 2008 first_quarter PHA Increasing number of pharmacists who specialize in geriatric pharmacy Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),HOUSE OF REPRESENTATIVES,SENATE   40000 0 0 2008-04-11T19:08:32-04:00
588163 RUBICON ADVISORS, LLC ff053ce3-ae80-4ca2-836f-517819e8892c Q1 RUBICON ADVISORS, LLC 315091 AMERICAN SOCIETY OF INTERVENTIONAL PAIN PHYSICIANS 2008 first_quarter PHA Healthcare: centers for Medicare & Medicaid Services (CMS), Reimbursements   30000   0 0 2008-04-13T11:08:06-04:00
588164 RUBICON ADVISORS, LLC 4b8e70fa-efd9-4104-9afc-6f7e89cbf180 Q1 RUBICON ADVISORS, LLC 315091 HEYL CHEMISCH-PHARMAZEUTISCHE FABRIK GMBH AND CO KG 2008 first_quarter PHA Healthcare: Pharmaceuticals, Bioshield   22500   0 0 2008-04-13T11:12:08-04:00
588165 RUBICON ADVISORS, LLC 192d10de-9c16-42cc-99e8-3ce4e8effab2 Q1 RUBICON ADVISORS, LLC 315091 INSMED INCORPORATED 2008 first_quarter PHA Pharmaceutical Issues   22500   0 0 2008-04-13T11:14:10-04:00
588166 RUBICON ADVISORS, LLC f6f97f40-7020-4b2f-b814-5d069a62a9e2 Q1 RUBICON ADVISORS, LLC 315091 TEVA PHARMACEUTICALS USA 2008 first_quarter PHA Healthcare: Pharmaceuticals, Prescription Drug User Fee   90000   0 0 2008-04-13T11:16:12-04:00
588167 RUBICON ADVISORS, LLC 3cd46413-0f98-416e-b895-6bd5568d8b6b Q1 RUBICON ADVISORS, LLC 315091 WATSON PHARMACEUTICALS INC 2008 first_quarter PHA Healthcare: Pharmaceuticals, Prescription Drug User Fee   102000   0 0 2008-04-13T11:20:15-04:00
588168 RUBICON ADVISORS, LLC 5b132b09-2ca7-4c70-b420-1a92d0a205eb Q1 RUBICON ADVISORS, LLC 315091 FLEMING PHARMACEUTICALS 2008 first_quarter PHA Healthcare: Pharmaceuticals, Bioshield   30000   0 0 2008-04-13T11:23:17-04:00
588169 RUBICON ADVISORS, LLC 5b7cd131-a6f3-42b4-a225-501c3d44a951 Q1 RUBICON ADVISORS, LLC 315091 GILEAD SCIENCES 2008 first_quarter PHA Healthcare: Pharmaceuticals   75000   0 0 2008-04-13T11:25:19-04:00
588312 ACADEMY OF MANAGED CARE PHARMACY 62011b73-0493-4497-90a6-9d8b780b6d52 Q1 ACADEMY OF MANAGED CARE PHARMACY 48793 ACADEMY OF MANAGED CARE PHARMACY 2008 first_quarter PHA Establishing a regulatory pathway for Food and Drug Administration approval of follow-on biologic products, Electronic prescribing of controlled substances, Regulation of online pharmacies, Importation of prescription drugs. HOUSE OF REPRESENTATIVES,SENATE   46688 0 0 2008-04-14T09:38:20-04:00
588339 VORYS, SATER, SEYMOUR AND PEASE LLP 82bb9def-4a99-4cd0-ad4a-9c812c54a482 Q1 VORYS, SATER, SEYMOUR AND PEASE LLP 40236 SOLVAY PHARMACEUTICALS INC 2008 first_quarter PHA Implementation of national strategy to prepare for pandemic influenza.   10000   0 0 2008-04-14T10:28:21-04:00
588444 POLICY ADVOCATES 0ac47abd-b8f8-4bf7-a54b-be89a8b765ac Q1 POLICY ADVOCATES 72018 PHOENIX CAPITAL MANAGEMENT LLC 2008 first_quarter PHA S.980: Online Pharmacy Consumer Protection Act of 2007 - Track and monitor. S.596: Safe Internet Pharmacy Act of 2007 - Track and monitor. HOUSE OF REPRESENTATIVES,SENATE 15000   0 0 2008-04-14T11:16:46-04:00
589746 TIMMONS AND COMPANY, INC. ade193b7-9dea-403c-8c81-eb95ee5292eb Q1 TIMMONS AND COMPANY, INC. 38164 TEVA PHARMACEUTICALS USA INC 2008 first_quarter PHA S. 28 - To amend title XVIII of the Social Security Act to require the use of generic drugs under the Medicare part D prescription drug program when available unless the brand name drug is determined to be medically necessary. S. 1505 - Affordable Biologics for Consumers Act. S. 1695 - To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, to promote innovation in the life sciences, and for other purposes. S. 242 - Pharmaceutical Market Access and Drug Safety Act of 2007. S. 251 - Pharmaceutical Market Access Act of 2007. S. 1082 - Prescription Drug User Fee Amendments of 2007. H.R. 2900 - Food and Drug Administration Amendments Act of 2007. H.R. 1956 - Patient Protection and Innovative Biologic Medicines Act. H.R. 1038 - Access to Life-Saving Medicine Act. H.R. 5629 - Pathway for Biosimilars Act HOUSE OF REPRESENTATIVES,SENATE 100000   0 0 2008-04-15T12:03:19-04:00
589786 RUBICON ADVISORS, LLC 8bc34aa6-1b9c-4529-b1a6-9b834e611751 Q4 RUBICON ADVISORS, LLC 315091 INSMED INCORPORATED 2008 fourth_quarter PHA Generic Biologics S. 1695   22500   0 0 2008-04-15T12:07:25-04:00
590185 BUCHANAN INGERSOLL & ROONEY PC b9fbf660-cad4-4d72-a614-2ce9319ff745 Q1 BUCHANAN INGERSOLL & ROONEY PC 55291 SHIRE PHARMACEUTICALS INC 2008 first_quarter PHA Education and policy issues. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2008-04-15T14:57:28-04:00
590207 POLICY DIRECTIONS INC. 6fd3e2b4-821a-4120-ada5-8981cd0b686f Q1 POLICY DIRECTIONS INC. 31747 ALPHARMA INC/PFIZER ANIMAL HEALTH (FORMERLY KNOWN AS ALPHARMA INC ) 2008 first_quarter PHA Antibiotics in animal foods Drug approvals S. 549/HR 962, all titles, to end the use of certain antibiotics in animal feed if those antibiotics are used in human medicine. S. 2313/HR3697, all titles, to require the manufacturers of antibiotics used in animal feed to make certain reports to FDA. HR 3610 to reform FDA regulation of federal imported and domestic food safety with emphasis on those titles related to the import of ingredients for food and drugs, as well as country-of-origin labeling. Monitor legislative and regulatory developments related to the Animal Drug User Fee Act reauthorization, with related developments of the Generic Animal Drug UserFee Act. Monitor developments of the Food & Drug Administrations development of its Advanced Feed Safety System related to the use of animal drugs in livestock and poultry feeds. Agriculture, Dept of (USDA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2008-04-15T15:04:11-04:00
590516 APTIV, PLC 3fce0cbf-faea-4c9a-aae5-66f38b87a529 Q1 APTIV, PLC 49054 APTIV PLC 2008 first_quarter PHA Implementation of Medicare prescription drug program Accessibility of generic drugs e-prescriptions Medical IT     190000 0 0 2008-04-15T16:35:38-04:00
590634 CONSULTANTS COLLABORATIVE -- MATTHEW R. SIMMONS e2c449aa-50dd-4604-af94-392cce516af4 Q1 CONSULTANTS COLLABORATIVE -- MATTHEW R. SIMMONS 311713 NATIONAL COALITION OF PHARMACEUTICAL DISTRIBUTORS 2008 first_quarter PHA Pharmaceutical Pedigree Related Policy/Legislation HOUSE OF REPRESENTATIVES,SENATE,Small Business Administration (SBA) 30000   0 0 2008-04-15T17:15:34-04:00
591268 NATIONAL COMMUNITY PHARMACISTS ASSOCIATION 2f94cd4b-341f-4704-979a-e89f174ee62c Q1 NATIONAL COMMUNITY PHARMACISTS ASSOCIATION 27478 NATIONAL COMMUNITY PHARMACISTS ASSOCIATION 2008 first_quarter PHA I. HR 971, the "Community Pharmacy Fairness Act of 2007"; S. 2161, the "Community Pharmacy Fairness Act of 2007"; CMS-2238-P, CMS-2238-FC and CMS-2238-IFC, the proposed, final rule, and interim final rule re implementation the Medicaid provisions of the Deficit Reduction Act of 2005; CMS-1270F, Final rule implementing the competitive acquisition program requirements for Durable Medical Equipment Prosthetics, Orthotics and Supplies; HR 2900, provision related to pedigree requirements; HR 4 and S.3, the "Medicare Prescription Drug Price Negotiation Act of 2007"; potential language not included in S. 2499, the "Medicare, Medicaid and SCHIP Extension Act of 2007" re e-prescribing; HR 1474, the "Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; CMS-6006-P, proposed rule requring a surety bond for all Medicare DMEPOS providers; Sec. 913 of FDAAA of 2007, relating to development of a standard numerical drug identifier; II. and also HR 3140, "Saving Our Community Pharmacies Act of 2007"; S. 1951, the "Fair Medicaid Drug Payment Act of 2007"; S. 1954, the "Pharmacy Access Improvement (PhAIm) Act of 2007"; HR 3700, the "Fair Medicaid Drug Payment Act of 2007"; Sec. 7002(b) of HR 2006 and PL 110-28, "Requirements for Use of Tamper-Resistant Prescription Pads Under the Medicaid Program", (the U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act of 2007); PL 110-181 -- HR 1585, HR 4986 and S. 1547, National Defense Authorization Act for Fiscal Year 2008, provisions related to pharmacy payment - sections 703 and 702 of HR 1585 and HR 4986 and Sec. 701 of S. 1547, all of II. done separately and as joint project with the National Association of Chain Drug Stores for the Coalition for Community Pharmacy Action.     120000 0 0 2008-04-16T10:49:01-04:00
591411 FAMILY RESEARCH COUNCIL a6f4306b-d732-4153-a8b6-3c24267c0d51 1A FAMILY RESEARCH COUNCIL 14110 FAMILY RESEARCH COUNCIL 2008 first_quarter PHA S. 1082 Prescription Drug User Fee Amendments of 2007 Use drug fees toward expediting drug development, reviewing drug applications and drug safety HOUSE OF REPRESENTATIVES,SENATE   30000 0 0 2008-04-16T11:20:47-04:00
591637 KNIGHT CAPITOL CONSULTANTS 9142b91f-42dc-4610-a595-371866a3e3aa Q1 KNIGHT CAPITOL CONSULTANTS 40036301 GENZYME CORPORATION 2008 first_quarter PHA S.1695 : A bill to amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, to promote innovation in the life sciences, and for other purposes. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2008-04-16T11:54:11-04:00
591706 CAPITOL HILL CONSULTING GROUP 125abcf5-b513-43df-b5c4-62c818e8fe3b Q1 CAPITOL HILL CONSULTING GROUP 72053 ASTELLAS PHARMA US 2008 first_quarter PHA Pharmaceutical and life sciences, including but not limited to: The Federal Food, Drug and Cosmetic Act; the Hatchwaxman Act; drug imporation; and drug safety HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2008-04-16T12:01:39-04:00
591828 PODESTA GROUP, INC. 45dfead4-faff-400c-b294-89fcfeec0c26 Q1 PODESTA GROUP, INC. 31680 BRISTOL-MYERS SQUIBB 2008 first_quarter PHA H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, drug safety provisions H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 623, Access to Life-Saving Medicine Act, follow-on biologics Drug importation Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2008-04-16T12:27:10-04:00
592116 CAPITOL HILL CONSULTING GROUP e417c5b6-7291-4329-8cf5-db700a47b5f1 Q1 CAPITOL HILL CONSULTING GROUP 72053 NOVARTIS CORPORATION 2008 first_quarter PHA Pharmaceutical and life sciences issues, including but not limited to: The Federal Food, Drug and Cosmetic Act; the Hatch-Waxman Act; drug safety HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2008-04-16T13:49:16-04:00
592141 PRICEWATERHOUSECOOPERS 56782d47-deed-47d4-8196-a82ce3090f46 Q1 PRICEWATERHOUSECOOPERS 10764 SCHERING-PLOUGH CORPORATION 2008 first_quarter PHA General issues affecting pharmaceutical companies Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 80000   0 0 2008-04-16T13:54:32-04:00
592169 UNIVERSITY OF PITTSBURGH MEDICAL CENTER 3c112bdb-defc-43af-8904-d1962c233b96 Q1 UNIVERSITY OF PITTSBURGH MEDICAL CENTER 32065 UNIVERSITY OF PITTSBURGH MEDICAL CENTER 2008 first_quarter PHA Issues related to the cost of prescription pharmaceuticals and the impact of that cost on hospitals and health care providers. Air Force, Dept of,Army, Dept of (Other),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE   260000 0 0 2008-04-16T13:59:27-04:00
592311 CAPITOL HILL CONSULTING GROUP d0ec3150-1b3e-4519-9ff3-199f6faf1590 Q1 CAPITOL HILL CONSULTING GROUP 72053 PURDUE PHARMA LLP 2008 first_quarter PHA general pharmaceutical issues, including but not limited to: The Federal Food, Drug and Cosmetic Act; the Controlled Drug Substances Act; drug imporation; and drug safety HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2008-04-16T14:29:39-04:00
592452 LATHAM & WATKINS LLP 4d1819a6-0e6f-4c90-9a52-05d9a35560f9 Q1 LATHAM & WATKINS LLP 22201 AMPHASTAR PHARMACEUTICALS 2008 first_quarter PHA Congressional oversight of the Food and Drug Administration and Environmental Protection Agency EPA rulemaking on CFC propellants Environmental Protection Agency (EPA),Food & Drug Administration (FDA)     0 0 2008-04-16T14:52:34-04:00
592509 AMYLIN PHARMACEUTICALS 69efd1d8-6547-4ef0-84c5-da3fdeaf690c Q1 AMYLIN PHARMACEUTICALS 308536 AMYLIN PHARMACEUTICALS 2008 first_quarter PHA HR 1038, Access to Life-Saving Medicines Act, follow-on biologics HR 1561, Enhancing Drug Safety and Innovation Act of 2007 HR 1956, Patient Protection and Innovative Biologics Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 623, Access to Life Saving Medicine Act, follow-on biologics Drug Importation Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   198000 0 0 2008-04-16T15:04:08-04:00
592732 ASSOCIATION OF NATIONAL ADVERTISERS, INC. cfea26c6-c582-46cb-8be8-1fad9da3c07e Q1 ASSOCIATION OF NATIONAL ADVERTISERS, INC. 4653 ASSOCIATION OF NATIONAL ADVERTISERS, INC. 2008 first_quarter PHA S. 2311 and H.R. 4083, Non-Prescription Drug Modernization Act of 2007, provisions to grant the FDA authority over advertising for over-the-counter drugs Federal Communications Commission (FCC),Federal Trade Commission (FTC),HOUSE OF REPRESENTATIVES,SENATE   250000 0 0 2008-04-16T15:54:33-04:00
592762 POLICY IMPACT COMMUNICATIONS, INC. b46cc7b8-6c6b-42ea-92df-ba30ab7f2b04 Q1 POLICY IMPACT COMMUNICATIONS, INC. 31758 STRATEGIC APPLICATIONS INTERNATIONAL LLC 2008 first_quarter PHA Development of legislation to restore Medicaid benefits for mentally ill offenders.   15000   0 0 2008-04-16T15:57:12-04:00
592949 UPS (UNITED PARCEL SERVICE) 8702ace4-4def-485b-9392-4237245a1ca8 Q1 UPS (UNITED PARCEL SERVICE) 39223 UPS (UNITED PARCEL SERVICE) 2008 first_quarter PHA Pedigree - pharmaceutical distribution Commerce, Dept of (DOC),Federal Aviation Administration (FAA),Government Accountability Office (GAO),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE,Transportation, Dept of (DOT),Transportation Security Administration (TSA),Treasury, Dept of,U.S. Customs & Border Protection,U.S. Trade Representative (USTR),White House Office   616000 0 0 2008-04-16T16:35:27-04:00
593338 AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS 386a6699-cea6-436e-a602-cfa44874d4bb Q1 AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS 3457 AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS 2008 first_quarter PHA Health Services and Resources Administration 340 B drug pricing program; proposed guidance on definition of patient, contract pharmacy and participation by children's hospitals. HR 3580, Food and Drug Administration Amendments Act of 2007, titles 8 and 9, all provisins. S.901. Reauthorization of National Health Service Corps. Provisions relating to loan forgiveness programs. Funding for Food and Drug Administration. HR 1956, Patient Protection and Innovative Biologic Medicines Act of 2007 and HR 1038, Access to Life Saving Medicine Act, HR 5629, Pathway for Biosimilars Act, provisions dealing with interchangability. HR 5491, Pharmacy Technician Training and Registration Act of 2008, all provisions. Proposal by FDA for a behind the counter drug category (public meeting and comments). Distribution of patient information and medication guides. Pharmacologic class in patient information. Proposal to transition Mevacor from prescription to over the counter status. Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE   200276 0 0 2008-04-16T18:17:20-04:00
593447 MCDERMOTT WILL & SCHULTE LLP 4485a56e-9bba-4643-8d19-9355e2484ac2 Q1 MCDERMOTT WILL & SCHULTE LLP 24338 RURAL REFERRAL CENTER/SOLE COMMUNITY HOSPITAL COALITION 2008 first_quarter PHA Amendments to Section 340(b) of the Public Health Service Act to gain eligibility for rural referral centers and sole community hospitals in the federal discount drug purchasing program. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 70000   0 0 2008-04-16T20:01:00-04:00
593451 PODESTA GROUP, INC. fe217b6d-04ae-4d3b-97ce-9ab9c11ec1bc Q1 PODESTA GROUP, INC. 31680 CUBIST PHARMACEUTICALS INC 2008 first_quarter PHA Medical Research Prescription drug/Federal Drug Admin/Center for Disease Control/Health and Human Service issues Antibiotic Resistance issues H. R. 1174, Healthy Hospitals Act H. R. 3697, Strategies to Address Antimicrobial Resistance Act H. R. 4352, Antimicrobial Task Force in public schools H. R. 4451, MRSA Research and Study Act S. 2278, Community and Healthcare Associated Infections Reduction Act S. 2313, Strategies to Address Antimicrobial Resistance Act S. 2525, MRSA Infection Prevention and Patient Protection Act S. 2526, Worker Infection Protection Act Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA) 40000   0 0 2008-04-16T20:01:19-04:00
593794 KIRKLAND & ELLIS LLP 67cf59e1-9252-47f2-b45a-32124abf1d1f 1A KIRKLAND & ELLIS LLP 21745 TEVA PHARMACEUTICALS USA 2008 first_quarter PHA House and Senate legislation on biologic medicines. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2008-04-17T09:58:52-04:00
594353 THE ACCORD GROUP bddd9c91-4a7c-49bc-8ad7-252dd49cb796 Q1 THE ACCORD GROUP 42785 CITIZENS FOR SUN PROTECTION 2008 first_quarter PHA Final promulgation of sunscreen monograph HOUSE OF REPRESENTATIVES,SENATE     0 0 2008-04-17T11:24:51-04:00
594541 THE ACCORD GROUP f01af9b1-1a45-4d3b-8d55-85758c65086e Q1 THE ACCORD GROUP 42785 CIBA SPECIALTY CHEMICALS CORP 2008 first_quarter PHA Sunscreen addititves Commerce, Dept of (DOC),HOUSE OF REPRESENTATIVES,SENATE,U.S. International Trade Commission (ITC) 37500   0 0 2008-04-17T11:59:33-04:00
594555 STANTON PARK GROUP 2152fe6d-a881-4d75-991a-759ffac4d0d1 Q1 STANTON PARK GROUP 83717 BARR LABORATORIES 2008 first_quarter PHA Generic Biologics (HR 1956, S. 1695, HR 1038, S 623, HR 5629); FDA REform (HR 2900, S 1082) office of Generic Drugs funding in Agrigultural Approps. (HR 3161, S 1859) HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2008-04-17T12:03:02-04:00
594664 STUNTZ DAVIS & STAFFIER, P.C. 04a18839-9d60-43e3-a0b9-5a71b472fd1f Q1 STUNTZ DAVIS & STAFFIER, P.C. 37141 PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA 2008 first_quarter PHA Drug safety issues. Pharmaceutical user fees. Foreign drug inspections. Drug reimportation.   10000   0 0 2008-04-17T12:29:21-04:00
594907 ELI LILLY AND COMPANY 3c9551d3-c9e9-4a6c-9ba9-1d756746d3de Q1 ELI LILLY AND COMPANY 13392 ELI LILLY AND COMPANY 2008 first_quarter PHA DTC (S 2445) Centers For Medicare and Medicaid Services (CMS),Commerce, Dept of (DOC),Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Security Agency (NSA),Natl Security Council (NSC),Office of Management & Budget (OMB),SENATE,State, Dept of (DOS),U.S. Trade Representative (USTR)   2895000 0 0 2008-04-17T13:27:11-04:00
595392 NOVO NORDISK INC. 63095fac-27d6-4a69-b367-4d06e4b65e44 Q1 NOVO NORDISK INC. 284790 NOVO NORDISK INC. 2008 first_quarter PHA H.R. 3610, Foreign Facility FDA Inspection User Fees; H.R. 1585, National Defense Authorization (portions relating to Tricare); protecting patient access in S. 877, Controlling the Abuse of Prescriptions Act; S. 2029, Physician Payments Sunshine Act of 2007; S. 1376, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),Patent & Trademark Office (PTO),SENATE   330000 0 0 2008-04-17T14:43:32-04:00
595570 AMERICAN COLLEGE OF CLINICAL PHARMACY c96b881c-aa16-4669-8e69-5aeac5b93d87 Q1 AMERICAN COLLEGE OF CLINICAL PHARMACY 57258 AMERICAN COLLEGE OF CLINICAL PHARMACY 2008 first_quarter PHA Coverage for direct patient care medication management services of qualified pharmacists Medicare Part B. Agency for Healthcare Research & Quality (AHRQ),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE   55950 0 0 2008-04-17T15:09:47-04:00
595608 GOODWIN PROCTER LLP b756a007-9572-4efd-8fc1-77676946ea12 Q1 GOODWIN PROCTER LLP 79756 TEVA PHARMACEUTICALS USA INC 2008 first_quarter PHA S.623 ACCESS TO LIFE SAVING MEDICINES ACT; H.R.1038 ACCESS TO LIFE SAVING MEDICINES ACT; S.1505 AFFORDABLE BIOLOGICS FOR CONSUMERS; S.1695 BIOLOGICS PRICE COMPETITION AND INNOVATION ACT OF 2007; H.R. 1956 THE PATIENT PROTECTION AND INNOVATIVE BIOLOGIC MEDICINE ACT; S.1145 PATENT REFORM ACT OF 2007; H.R. 1908 PATENT REFORM ACT OF 2007 (ALL PROVISIONS FOR ALL BILLS) HOUSE OF REPRESENTATIVES,SENATE 150000   0 0 2008-04-17T15:18:05-04:00
595659 JENNINGS POLICY STRATEGIES e1a1e551-b20d-4502-97f8-21de63361427 Q1 JENNINGS POLICY STRATEGIES 64656 GENERAL MOTORS CORP 2008 first_quarter PHA -Advocated for cost containment policies including generic access and comparative effectiveness (including H.R. 1038 and S. 623) and policies that promote competition in the pharmaceutical marketplace -Advocated for policies promoting broad health coverage reform, including support for initiatives designed to reform retiree health liabilities that undermine competitiveness and policies related to Medicare coverage of end-stage renal disease services HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2008-04-17T15:24:29-04:00
596115 GENZYME CORPORATION f279eac5-af20-407b-b53d-aa53568c539d Q1 GENZYME CORPORATION 16054 GENZYME CORPORATION 2008 first_quarter PHA H.R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H.R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics H.R. 5629, Pathway for Biosimilars Act S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, Follow-on Biologics S. 2029, Physician Payments Sunshine Act of 2007 S. 623, Access to Life-Saving Medicine Act, follow-on biologics Neglected Disease Issues Issues related to Drug Safety, Generic Biologics & Drug Approvals H.R. 380, "Pharmaceutical Market Access and Drug Safety act of 2007" - Importation. S.251, Pharmaceutical Market Access & Drug Safety Act of 2007" - Importation. S.242, "Pharmaceutical Market Access & Drug Safety Act of 2007" H.R. 1561, Enhancing Drug Safety and Innovation Act of 2007 Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   640000 0 0 2008-04-17T16:17:26-04:00
596361 PARRY, ROMANI, DECONCINI & SYMMS 8011293d-0a95-48af-98a0-c0608a15467d Q1 PARRY, ROMANI, DECONCINI & SYMMS 30792 INTL ACADEMY OF COMPOUNDING PHARMACISTS 2008 first_quarter PHA Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No legislation introduced yet. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2008-04-17T16:55:31-04:00
596466 AMERICAN FEDERATION OF STATE, COUNTY AND MUNICIPAL EMPLOYEES fe9012ac-8da4-401e-b4d5-07fd81ca551e Q1 AMERICAN FEDERATION OF STATE, COUNTY AND MUNICIPAL EMPLOYEES 2321 AMERICAN FEDERATION OF STATE COUNTY AND MUNICIPAL EMPLOYEES 2008 first_quarter PHA FDA authority to approve safe and effective, more affordable biogeneric drugs Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   480000 0 0 2008-04-17T17:10:08-04:00
596627 DOW LOHNES GOVERNMENT STRATEGIES LLC 5b0021e0-5508-4c4e-abbb-a9985d1ee02c Q1 DOW LOHNES GOVERNMENT STRATEGIES LLC 316013 APOTEX CORP 2008 first_quarter PHA H.R. 3700 Fair Medicaid Drug Payment Act of 2007, provisions related to regulation of generic drugs and consumer access; H.R. 1902 Protecting Consumer Access to Generic Drugs Act of 2007, all provisions related to generic drug consumer access; H.R. 3610 Food and Drug Import Safety Act of 2007, provisions related to drug safety; H.R. 5629 Pathway for Biosimilars Act, all provisions related to FDA licensure of biogeneric drugs HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2008-04-17T17:32:38-04:00
596710 ATRIUM HEALTH-FORMERLY KNOWN AS CAROLINAS HEALTHCARE SYSTEM ced0616e-b38e-422e-a190-ce2e2f7d639a Q1 ATRIUM HEALTH-FORMERLY KNOWN AS CAROLINAS HEALTHCARE SYSTEM 58534 ATRIUM HEALTH - FORMERLY KNOWN AS CAROLINAS HEALTHCARE SYSTEM 2008 first_quarter PHA HR 2606, HR 1376. Any language expanding the 340B drug discount rebate to inpatient pharmaceuticals. Congressional Budget Office (CBO),HOUSE OF REPRESENTATIVES,SENATE   160359 0 0 2008-04-17T17:46:52-04:00
596927 VAN NESS FELDMAN, LLP 456b0cb1-9126-4068-85c8-dca99d44962b Q1 VAN NESS FELDMAN, LLP 39815 MCKESSON CORPORATION 2008 first_quarter PHA S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007 H.R. 380, Pharmaceutical Market Access and Drug Safety Act of 2007 S. 251, Pharmaceutical Market Access Act of 2007 S. 596, Safe Internet Pharmacy Act of 2007 S. 980, Online Pharmacy Consumer Protection Act of 2007 H.R. 971, Community Pharmacy Fairness Act of 2007 S. 885, Community Pharmacy Fairness Act of 2007 H.R. 3140, Saving Our Community Pharmacies Act of 2007 H.R. 3193, Access to Community Pharmacy Preservation Act of 2007 S. 1951, Fair Medicaid Drug Payment Act of 2007 H.R. 3700, Fair Medicaid Drug Payment Act of 2007 H.R. 780, Counterfeit Drug Prevention Act of 2007 S. 2085, Patient and Pharmacy Protection Act of 2007 S. 207, Combat Methamphetamine Enhancement Act of 2007 Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2008-04-17T18:40:35-04:00
597121 CGCN GROUP, LLC 34c4e9b2-468c-462b-9287-6ebc364da6ad Q1 CGCN GROUP, LLC 76992 BARR PHARMACEUTICALS INC (FORMERLY BARR LABORATORIES INC ) 2008 first_quarter PHA H.R.3161, S.1859, Funding for the Office of Generic Drugs, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act H.R.2900, S.1082, Food and Drug Administration Reform HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2008-04-17T21:44:46-04:00
597296 ABELL, HENRY & ASSOCIATES, LLC 3cd09ce2-dfbd-4567-9f9b-8c2de0f31c7d Q1 ABELL, HENRY & ASSOCIATES, LLC 318378 EXPRESS SCRIPTS INCORPORATED 2008 first_quarter PHA DoD Pharmacy Issues       0 0 2008-04-18T08:45:41-04:00
597346 UNIVERSITY OF CONNECTICUT 085ed782-a174-4b31-ae98-1682326dd875 Q1 UNIVERSITY OF CONNECTICUT 39382 UNIVERSITY OF CONNECTICUT 2008 first_quarter PHA Implementation of Prescription Drug User Fee Amendments 2007 (Public Law 110-85), Drug safety related issues. Defense, Dept of (DOD),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE   60000 0 0 2008-04-18T09:12:30-04:00
597989 FABIANI & COMPANY 2dd29d46-878c-4ae6-b15e-a1a9b9c8898e Q1 FABIANI & COMPANY 72576 ALNYLAM PHARMACEUTICALS 2008 first_quarter PHA S.1145 Patent Reform Act Provisions relating to the apportionment of damages HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2008-04-18T10:42:40-04:00
598117 KEVIN MCGUINESS PLLC ba1f6ac8-90fd-493e-a2ff-ed31279a7376 Q1 KEVIN MCGUINESS PLLC 299811 FEDERATION OF AMERICAN HOSPITALS 2008 first_quarter PHA The Community Pharmacy Fairness Act, HR 971/S. 2161 HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2008-04-18T10:56:55-04:00
598131 KEVIN MCGUINESS PLLC 4875a95f-ce20-46ef-98e1-d439dbc1302e Q1 KEVIN MCGUINESS PLLC 299811 BARR LABS 2008 first_quarter PHA Issues that relate to legislation addressing the FDA, Bioshield, and generic biologics. S. 3818, HR 2795, entire legislation addressing changes to the patent process; other potential legislation to reform the patent process. S. 316, Preserve Access to Affordable Biologics, S. 623/HR 1032, Access to Life Saving Medicine Act. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2008-04-18T10:59:05-04:00
598806 NATIONAL ASSOCIATION OF CHAIN DRUG STORES df250d56-0aae-49b0-bfa2-697906b59056 Q1 NATIONAL ASSOCIATION OF CHAIN DRUG STORES 26672 NATIONAL ASSOCIATION OF CHAIN DRUG STORES 2008 first_quarter PHA See addendum. 1.S.242/H.R.380, the Pharmaceutical Market Access and Drug Safety Act of 2007, as related to provisions governing the importation of prescription drugs. 2.S.251, the Pharmaceutical Market Access Act of 2007, all provisions governing the importation of prescription drugs. 3.S. 484, the Enhancing Drug Safety and Innovation Act of 2007, all provisions related to the safety of prescription medicines. 4.S. 604, the Military Health Care Protection Act, as related to provider participation in the Department of Defense TRICARE program. 5.S. 980, Online Pharmacy Consumer Protection Act of 2007, as related to the regulation of online pharmacies. 6.S. 1200, Indian Health Care Improvement Act Amendments of 2007, all provisions related to reducing fraud and abuse in the Medicare program. 7.S. 1276/H.R.2747, the Methamphetamine Production Prevention Act of 2007, as related to the distribution of legal substances used in the production of methamphetamine. 8.S. 1693, the Wired for Health Care Quality Act of 2007, as related to improving health information technology. 9.S. 1695, the Biologics Price Competition and Innovation Act of 2007, as related to the approval of generic biopharmaceuticals. 10.S. 1827, Pharmacist Access and Recognition in Medicare (PhARM) Act of 2007 as related to provider participation in the Medicare program. 11.S.1915, Electronic Prescription Drug Act of 2007, as related to the regulation of electronic prescribing of pharmaceuticals 12.S.1951/H.R.3700, Fair Medicaid Drug Payment Act of 2007, as related to Medicaid provider reimbursement. 13.S.1954, Pharmacy Access Improvement (PhAIm) Act of 2007, as related to access standards to pharmacies. 14.S.2013/H.R.3090, Patient and Pharmacy Protection Act of 2007, as related to prescription requirements in the Medicaid program. 15.S.2071, Combat Methamphetamine Enhancement Act of 2007, as related to the distribution of legal substances used in the production of methamphetamine. 16.S.2274, Dextromethorphan Abuse Reduction Act of 2007, as related to st… Centers For Medicare and Medicaid Services (CMS),Consumer Product Safety Commission (CPSC),Defense, Dept of (DOD),Drug Enforcement Administration (DEA),Executive Office of the President (EOP),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Labor, Dept of (DOL),Office of Natl Drug Control Policy (NDCP),Office of Personnel Management (OPM),President of the U.S.,SENATE   370000 0 0 2008-04-18T11:54:18-04:00
598991 THE DUBERSTEIN GROUP INC. 9737aa2d-3348-4b17-83e8-da07b2b125c4 Q1 THE DUBERSTEIN GROUP INC. 12675 AMERICA'S HEALTH INSURANCE PLANS 2008 first_quarter PHA Pharmacy issues - S 623, Access to Life-Saving Medicine Act; HR 1038, Access to Life-Saving Medicine Act; S 1505, Affordable Biologics for Consumers Act; S 316, Preserve Access to Affordable Generics Act; S 1695, Biologics Price Competition and Innovation Act of 2007; HR 971, Community Pharmacy Fairness Act of 2007; S 885, Community Pharmacy Fairness Act of 2007; S 980, Online Pharmacy Consumer Protection Act of 2007; HR 5629, Pathway for Biosimilars Act. HOUSE OF REPRESENTATIVES,SENATE,White House Office 100000   0 0 2008-04-18T12:13:55-04:00
599271 TARPLIN, DOWNS & YOUNG, LLC 2c29674f-21f5-4a5f-bc5a-9a52ce3eef4d Q1 TARPLIN, DOWNS & YOUNG, LLC 304736 WYETH 2008 first_quarter PHA *see addendum page FDAAA Implementation Biosimilars H.R. 1956 - Patient Protection and Innovative Biologic Medicines Act of 2007 S. 623/H.R.1038 - Access to Life- Saving Medicine Act, Follow-On Biologics S. 1695 - Biologics Price Competition and Innovation Act of 2007 S. 1505 - Affordable Biologics for Consumers Act H.R. 5629, the "Pathway for Biosimilars Act." Import Safety H.R. 3610 - Food and Drug Import Safety Act of 2007 ***, no specific bill(s), Biosimilars, Drug Safety, Prescription Drug Importation, Import Safety Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office 40000   0 0 2008-04-18T12:56:15-04:00
599278 TROUTMAN STATEGIES a52637ca-7def-480e-bd77-e836247dd6e5 1T TROUTMAN STATEGIES 81511 BRANDED PHARMACEUTICAL ASSOCIATION 2008 first_quarter PHA Seek legislative and regulatory support for Desi drugs Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 10000   0 1 2008-04-18T12:58:11-04:00
599309 UNIVERSITY OF ILLINOIS 3136aa67-b5c9-41fc-9874-bfd0781128be Q1 UNIVERSITY OF ILLINOIS 39427 UNIVERSITY OF ILLINOIS 2008 first_quarter PHA H.R. 4054 - Prevention Through Affordable Access Act, Sec. 2, all provisions relating to restoring and protecting access to discount drug prices for university-based and safety-net clinics; (a), all provisions relating to restoring normal pricing. S. 2347 - Prevention Through Affordable Access Act, Sec. 2, all provisions relating to restoring and protecting access to discount drug prices for university-based and safety-net clinics. Agriculture, Dept of (USDA),Defense, Dept of (DOD),Education, Dept of,Energy, Dept of,Federal Aviation Administration (FAA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Institutes of Health (NIH),Natl Science Foundation (NSF),Patent & Trademark Office (PTO),SENATE,State, Dept of (DOS)   60000 0 0 2008-04-18T13:01:31-04:00
599432 PARRY, ROMANI, DECONCINI & SYMMS 07f3f6de-6c93-4ada-8d51-4be453da4e53 Q1 PARRY, ROMANI, DECONCINI & SYMMS 30792 SUNOVION PHARMACEUTICALS INC (FORMERLY SEPRACOR INC ) 2008 first_quarter PHA No specific legislation or bills introduced at this time. Medicare reimbursement issues.   20000   0 0 2008-04-18T13:18:38-04:00
599579 PARRY, ROMANI, DECONCINI & SYMMS 523a48bb-2217-42f1-a86c-a09d254aef30 1T PARRY, ROMANI, DECONCINI & SYMMS 30792 SIDLEY AUSTIN LLP (FOR SEPRACOR) 2008 first_quarter PHA Medicare reimbursement issues. Ensure appropriate reimbursement for branded drugs. No legislation introduced yet. HOUSE OF REPRESENTATIVES,SENATE 40000   0 1 2008-04-18T13:34:19-04:00
600184 DUANE MORRIS GOVERNMENT AFFAIRS 55a62901-d25a-402b-a269-b2b2adc7c267 Q1 DUANE MORRIS GOVERNMENT AFFAIRS 49657 CB DISTRIBUTORS INC 2008 first_quarter PHA Regulation of over-the-counter asthma-cough medicines. Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2008-04-18T14:25:08-04:00
600343 AVENUE SOLUTIONS 1246f9b1-7eca-4a9b-8893-836c4cb72d61 Q1 AVENUE SOLUTIONS 72111 EXPRESS SCRIPTS INC 2008 first_quarter PHA HR 971 Community Pharmacy Fairness Act of 2007 HR 2970 Pharmacy Benefit Manager Transparency Act of 2007 HR 3140 Saving Our Community Pharmacies Act of 2007 HR 3090 Patient and Pharmacy Protection Act of 2007 HR 3193 Access to Community Pharmacy Preservation Act of 2007 S 885 Community Pharmacy Fairness Act of 2007 S 980 Online Pharmacy Consumer Protection Act of 2007 S 1827 Pharmacist Access and Recognition in Medicare (PhARM) Act of 2007 S 1954 Pharmacy Access Improvement (PhAIm) Act of 2007 S 2013 Patient and Pharmacy Protection Act of 2007 S 2085 Patient and Pharmacy Protection Act of 2007 S 2161 Community Pharmacy Fairness Act of 2007 Internet Pharmacies Off-Label Use of Prescription Drugs. HOUSE OF REPRESENTATIVES,SENATE 75000   0 0 2008-04-18T14:39:36-04:00
600351 BLUE CROSS AND BLUE SHIELD OF KANSAS, INC. ee3d6ef4-8c1b-49e6-85e6-0479bd55751f Q1 BLUE CROSS AND BLUE SHIELD OF KANSAS, INC. 323876 BLUE CROSS AND BLUE SHIELD OF KANSAS INC 2008 first_quarter PHA E-prescribing Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),SENATE,White House Office     0 0 2008-04-18T14:41:04-04:00
600386 ANIMAL HEALTH INSTITUTE c0f2eb6f-e116-40c1-9dd8-4d88aced2da2 Q1 ANIMAL HEALTH INSTITUTE 4037 ANIMAL HEALTH INSTITUTE 2008 first_quarter PHA Animal drug and biologics regulation and approval process, Antibiotic Resistance; Animal Drug User Fee Act; HR 962 & S 549, Preservation of Antibiotics for Medical Treat Act of 2007; HR 2419, Farm, Nutrition, and Bioenergy Act of 2007; S 2302, Food And Energy Security Act of 2007; S 2313, Strategies to Address Antimicrobial Resistance Act; HR 3697, to Amend the Public Health Service Act to Address Antimicrobial Resistance; HR 2900, Agriculture, Dept of (USDA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE   30000 0 0 2008-04-18T14:44:12-04:00
600495 HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA) a453bd82-7756-40be-a9be-c2abfbd9be81 Q1 HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA) 28776 HEALTHCARE DISTRIBUTION ALLIANCE (FORMERLY - HDMA) 2008 first_quarter PHA Importation of prescription drugs (H.R. 3161, S. 1644) Rx Pedigree Methaphetamine/Pseudoephedrine Regulation (S. 2071) Internet Pharmacy (S. 980) Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE   165000 0 0 2008-04-18T14:55:03-04:00
600574 AVENUE SOLUTIONS 0c0915db-80bc-4c14-b81d-4af66a2a1716 Q1 AVENUE SOLUTIONS 72111 BLUE CROSS BLUE SHIELD ASSOCIATION 2008 first_quarter PHA E-prescribing   81000   0 0 2008-04-18T15:02:28-04:00
600747 KRIEG DEVAULT LLP 9e72c616-8cc5-449d-9326-41db0dc8cecc Q1 KRIEG DEVAULT LLP 21905 DR ERICH HUGO CERNY 2008 first_quarter PHA Patent extension HOUSE OF REPRESENTATIVES,SENATE     0 0 2008-04-18T15:13:36-04:00
600890 SHIRE PHARMACEUTICALS LLC 36d4b292-9dba-4581-a23d-6a11474c7419 Q1 SHIRE PHARMACEUTICALS LLC 323477 SHIRE PHARMACEUTICALS LLC 2008 first_quarter PHA Biosimilars legislation; orphan provisions; ADHD Agency for Healthcare Research & Quality (Line 17) HOUSE OF REPRESENTATIVES,SENATE   171000 0 0 2008-04-18T15:23:08-04:00

Next page

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE lobbying_activities (
            id INTEGER PRIMARY KEY,
            filing_uuid TEXT NOT NULL,
            filing_type TEXT NOT NULL,
            registrant_name TEXT NOT NULL,
            registrant_id INTEGER,
            client_name TEXT NOT NULL,
            filing_year INTEGER NOT NULL,
            filing_period TEXT NOT NULL,
            issue_code TEXT,
            specific_issues TEXT,
            government_entities TEXT,
            income_amount INTEGER,
            expense_amount INTEGER,
            is_no_activity INTEGER DEFAULT 0,
            is_termination INTEGER DEFAULT 0,
            received_date TEXT,
            CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
                REFERENCES lobbying_filings_raw(filing_uuid)
        );
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);
Powered by Datasette · Queries took 1747.538ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API